ArticleESMO open2022

The clinical utility of comprehensive measurement of autoimmune disease-related antibodies in patients with advanced solid tumors receiving immune checkpoint inhibitors: a retrospective study.

N Izawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.